Idorsia Ltd (IDIA.SW)

CHF 1.3

(2.45%)

Total Liabilities Summary of Idorsia Ltd

Idorsia Ltd's latest annual total liabilities in 2023 was 1.46 Billion CHF , down -6.16% from previous year.
Idorsia Ltd's latest quarterly total liabilities in 2024 Q3 was 1.38 Billion CHF , down -19.27% from previous quarter.
Idorsia Ltd reported annual total liabilities of 1.56 Billion CHF in 2022, up 13.52% from previous year.
Idorsia Ltd reported annual total liabilities of 1.37 Billion CHF in 2021, up 62.23% from previous year.
Idorsia Ltd reported quarterly total liabilities of 1.71 Billion CHF for 2024 Q1, up 16.92% from previous quarter.
Idorsia Ltd reported quarterly total liabilities of 1.38 Billion CHF for 2024 Q3, down -19.27% from previous quarter.

Annual Total Liabilities Chart of Idorsia Ltd (2023 - 2016)

Historical Annual Total Liabilities of Idorsia Ltd (2023 - 2016)

Year	Total Liabilities	Total Liabilities Growth
2023	1.46 Billion CHF	-6.16%
2022	1.56 Billion CHF	13.52%
2021	1.37 Billion CHF	62.23%
2020	849.88 Million CHF	1.19%
2019	839.85 Million CHF	12.11%
2018	749.14 Million CHF	35.62%
2017	552.37 Million CHF	35.67%
2016	407.15 Million CHF	0.0%

Year	Total Liabilities	Total Liabilities Growth
2024 Q2	1.71 Billion CHF	-0.27%
2024 Q1	1.71 Billion CHF	16.92%
2024 Q3	1.38 Billion CHF	-19.27%
2023 Q3	1.48 Billion CHF	-5.39%
2023 Q4	1.46 Billion CHF	-1.04%
2023 FY	1.46 Billion CHF	-6.16%
2023 Q1	1.55 Billion CHF	-0.42%
2023 Q2	1.56 Billion CHF	0.65%
2022 Q2	1.39 Billion CHF	1.31%
2022 Q4	1.56 Billion CHF	-0.17%
2022 FY	1.56 Billion CHF	13.52%
2022 Q1	1.37 Billion CHF	-0.1%
2022 Q3	1.56 Billion CHF	12.36%
2021 Q1	809.01 Million CHF	-4.81%
2021 FY	1.37 Billion CHF	62.23%
2021 Q4	1.37 Billion CHF	-4.98%
2021 Q3	1.45 Billion CHF	75.78%
2021 Q2	825.46 Million CHF	2.03%
2020 FY	849.88 Million CHF	1.19%
2020 Q1	832.17 Million CHF	-0.91%
2020 Q2	838.63 Million CHF	0.78%
2020 Q3	838.88 Million CHF	0.03%
2020 Q4	849.88 Million CHF	1.31%
2019 Q2	825.39 Million CHF	2.51%
2019 FY	839.85 Million CHF	12.11%
2019 Q4	839.85 Million CHF	4.0%
2019 Q1	805.18 Million CHF	7.48%
2019 Q3	807.56 Million CHF	-2.16%
2018 Q1	535.96 Million CHF	-2.97%
2018 FY	749.14 Million CHF	35.62%
2018 Q3	757.59 Million CHF	39.8%
2018 Q2	541.93 Million CHF	1.11%
2018 Q4	749.14 Million CHF	-1.12%
2017 Q1	412.04 Million CHF	0.0%
2017 FY	552.37 Million CHF	35.67%
2017 Q4	552.37 Million CHF	20.0%
2017 Q3	460.32 Million CHF	2.49%
2017 Q2	449.13 Million CHF	9.0%
2016 FY	407.15 Million CHF	0.0%

Peer Total Liabilities Comparison of Idorsia Ltd

Name	Total Liabilities	Total Liabilities Difference
Addex Therapeutics Ltd	3.49 Million CHF	-41906.224%
BB Biotech AG	304.9 Million CHF	-381.704%
Basilea Pharmaceutica AG	183.29 Million CHF	-701.297%
Evolva Holding SA	4.27 Million CHF	-34251.062%
Kuros Biosciences AG	19.19 Million CHF	-7551.943%
Molecular Partners AG	21.92 Million CHF	-6599.421%
Relief Therapeutics Holding AG	24.16 Million CHF	-5978.611%
Santhera Pharmaceuticals Holding AG	49.68 Million CHF	-2855.992%